India’s first coronavirus vaccine COVAXIN processed by Hyderabad-based Bharat Biotech has got sanction from the Drug Controller General of India (DCGI) to start with human clinical trials. The company on its website said it is blithesome to promulgate its 3 COVID-19 vaccines in copartnership with the University of WISCONSIN, ICMR, and Thomas Jefferson University.

Made in India

Coronavirus vaccine –COVAXIN– is India’s first locale inactivated vaccine for the highly infectious and deadly disease COVID-19.

Producer of Covaxin?

Bharat Biotech’s COVAXIN has got approval from the Drug Controller General of India CDSCO (The Central Drugs Standard Control Organisation), Ministry of Health & Family Welfare to being with Phase I and II Human clinical trials after the company presented results generated from pre-clinical studies, demonstrating safety and immune response.

Bharat Biotech Chairman, Managing Director has to say on COVAXIN

Bharat Biotech’s Chairman and Managing Director, Dr. Krishna Ella says “We are proud to declare COVAXIN, India’s first locale vaccine Contradictory COVID-19. The copartnership with ICMR and NIV was instrumental in the development of this vaccine.

He also compiled, “Our R&D and Manufacturing teams worked indefatigably to unfurl our possessory technologies towards this platform,” he said. Prompted through the national regulatory protocols, the company hasty its objective in completing the pervasive pre-clinical studies.

Several other Indian companies working on the COVID-19 vaccine

Apart from Bharat Biotech, 5 other Indian firms are also working to make a vaccine that has had an unfortunate impact thenceforth the world impressing the health and wealth of millions of people. Not only India, but pharma companies, researchers, scientists are working day-night across nations to find a vaccine for coronavirus as present medications accessible in the world have not been effective to contain the disease.

LEAVE A REPLY

Please enter your comment!
Please enter your name here